Alnylam Pharmaceuticals: Clinical Trials & Research Profile

Biopharma Industry (Cambridge, MA) · Primary Focus: Rare Genetic, Women's Health, and Other

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Cambridge, MA)
Primary Therapeutic AreaRare Genetic, Women's Health, and Other
Active Phase II & III Studies13 active (9 recruiting now)
Total Tracked Studies (2018 to 2026)29 (18 with California sites)
Completed vs Early-Stopped Studies11 completed / 5 stopped (17.2% stop rate)
Median Closed Enrollment47 participants
FDA Drugs@FDA Original Approvals4 all-time (4 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Alnylam Pharmaceuticals across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk